AntineoplasticsEGFR and KRAS mutations with acquired resistance to crizotinib: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1515卷 / 1期
关键词：
D O I：
10.1007/s40278-014-2726-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：31 / 31
相关论文
共 50 条
  • [31] Crizotinib/nivolumab/tepotinibNausea and drug resistance: case report
    Reactions Weekly, 2021, 1877 (1) : 122 - 122
  • [32] Crizotinib/gefitinib/osimertinibEmergence of drug resistance: case report
    Reactions Weekly, 2021, 1873 (1) : 86 - 86
  • [33] EMERGENCE OF KRAS MUTATIONS AND ACQUIRED RESISTANCE TO ANTI EGFR THERAPY IN COLORECTAL CANCER
    Misale, S.
    Yaeger, R.
    Hobor, S.
    Scala, E.
    Janakiraman, M.
    Liska, D.
    Valtorta, E.
    Schiavo, R.
    Buscarino, M.
    Siravergna, G.
    Bencardino, K.
    Cercek, A.
    Chen, C.
    Veronese, S.
    Zanon, C.
    Sartore-Bianchi, A.
    Gambacorta, M.
    Gallicchio, M.
    Vakiani, E.
    Boscaro, V.
    Medico, E.
    Weiser, M.
    Siena, S.
    di Nicolantonio, F.
    Solit, D.
    Bardelli, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [34] Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case report
    Campos-Gomez, Saul
    Lara-Guerra, Humberto
    Routbort, Mark J.
    Lu, Xinyan
    Simon, George R.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (02): : E254 - E257
  • [35] AntiviralsResistance associated mutations leading to acquired resistance in Hepatitis C infection: case report
    Reactions Weekly, 2017, 1643 (1) : 40 - 40
  • [36] AntineoplasticsAcquired crizotinib resistance, constipation and loss of appetite: case report
    Reactions Weekly, 2019, 1778 (1) : 50 - 50
  • [37] CrizotinibDevelopment of crizotinib resistance in metastatic lung cancer: case report
    Reactions Weekly, 2018, 1683 (1) : 229 - 229
  • [38] CrizotinibDevelopment of crizotinib resistance leading to disease progression: case report
    Reactions Weekly, 2016, 1621 (1) : 83 - 83
  • [39] CrizotinibDevelopment of crizotinib-resistance in lung adenocarcinoma: case report
    Reactions Weekly, 2017, 1635 (1) : 96 - 96
  • [40] GefitinibDevelopment of acquired resistance: case report
    Reactions Weekly, 2017, 1680 (1) : 151 - 151
12345